Skip to main content
SpringerLink
Log in

Immunodeficiency Disorders Resulting in Malabsorption

  • Chapter
  • First Online:
Textbook of Pediatric Gastroenterology, Hepatology and Nutrition

Abstract

Primary immunodeficiencies are a group of at least 200 disorders; gastrointestinal (GI) diseases affect about 5–50% of patients with primary immunodeficiencies and are often the initial presenting manifestation. These manifestations, showing the same clinical features, could mimic other diseases such as celiac disease, food allergy, or inflammatory bowel diseases (IBD), but they are often unresponsive to conventional therapies. Diagnostic algorithm in child with recurrent GI symptoms needs for a stage approach, in order to rule out differential diagnosis, to perform screening immunological tests, and to refer an immunologist when an immunodeficiency is suspected. In pediatric patients, GI manifestations of primary immunodeficiencies are mainly induced by infection, inflammation, or autoimmunity, and severe malnutrition can occur in 50–60% of these patients. In adult patients, malignancy could be a frequent additional condition.

Due to the high incidence of GI disease in these patients, early evaluation of the GI tract is useful for children with certain or suspect immunodeficiency, to prevent potentially irreversible tissue damage.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Modell V, Orange JS, Quinn J, et al. Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician reported outcomes. Immunol Res. 2018;66:367–80.

    CAS  Google Scholar 

  2. Subbarayan A, Colarusso G, Hughes SM, Gennery AR, Slatter M, Cant AJ, et al. Clinical features that identify children with primary immunodeficiency diseases. Pediatrics. 2011;127:810–6.

    Google Scholar 

  3. Agarwal S, Mayer L. Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol. 2013;11:1050–63.

    Google Scholar 

  4. Lehman H. Skin manifestations of primary immune deficiency. Clin Rev Allergy Immunol. 2014;46(2):112–9.

    CAS  Google Scholar 

  5. Canani RB, Castaldo G, Bacchetta R, Martín MG, Goulet O. Congenital diarrhoeal disorders: advances in this evolving web of inherited enteropathies. Nat Rev Gastroenterol Hepatol. 2015;12(5):293–302.

    CAS  Google Scholar 

  6. Passariello A, Terrin G, Baldassarre ME, De Curtis M, Paludetto R, Berni CR. Diarrhea in neonatal intensive care unit. World J Gastroenterol. 2010;16(21):2664–8.

    Google Scholar 

  7. Seidel MG, Kindle G, Gathmann B, et al. The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. 2019;7(6):1763–70.

    Google Scholar 

  8. Chinen J, Shearer WT. Secondary immunodeficiencies, including HIV infection. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S195–203.

    Google Scholar 

  9. Srivastava S, Wood P. Secondary antibody deficiency – causes and approach to diagnosis. Clin Med (Lond). 2016;16(6):571–6.

    Google Scholar 

  10. Singh K, Chang C, Gershwin ME. IgA deficiency and autoimmunity. Autoimmun Rev. 2014;13:163–77.

    CAS  Google Scholar 

  11. Yel L. Selective IgA deficiency. J Clin Immunol. 2010;30:10–6.

    CAS  Google Scholar 

  12. Yazdani R, Azizi G, Abolhassani H, Aghamohammadi A. Selective IgA deficiency: epidemiology, pathogenesis, clinical phenotype, diagnosis, prognosis and management. Scand J Immunol. 2017;85(1):3–12.

    CAS  Google Scholar 

  13. Kobrynski LJ, Mayer L. Diagnosis and treatment of primary immunodeficiency disease in patients with gastrointestinal symptoms. Clin Immunol. 2011;139:238–48.

    CAS  Google Scholar 

  14. Panarelli NC, Yantiss RK. Inflammatory and infectious manifestations of immunodeficiency in the gastrointestinal tract. Mod Pathol. 2018;31:844–61.

    Google Scholar 

  15. Agarwal S, Cunningham-Rundles C. Gastrointestinal manifestations and complications of primary immunodeficiency disorders. Immunol Allergy Clin N Am. 2019;39:81–94.

    Google Scholar 

  16. Cerutti A. The regulation of IgA class switching. Nat Rev Immunol. 2008;8:421–34.

    CAS  Google Scholar 

  17. Lougaris V, Ferrari S, Cattalini M, et al. Autosomal recessive agammaglobulinemia: novel insights from mutations in Ig-beta. Curr Allergy Asthma Rep. 2008;8:404–8.

    CAS  Google Scholar 

  18. El-Sayed ZA, Abramova I, Aldave JC, et al. X-linked agammaglobulinemia (XLA): phenotype, diagnosis, and therapeutic challenges around the world. World Allergy Organ J. 2019;12(3):100018–38.

    CAS  Google Scholar 

  19. Chun JK, Lee TJ, Song JW, et al. Analysis of clinical presentations of Bruton disease: a review of 20 years of accumulated data from pediatric patients at severance hospital. Yonsei Med J. 2008;49:28–36.

    CAS  Google Scholar 

  20. Barmettler S, Otani IM, Minhas J, et al. Gastrointestinal manifestations in X-linked agammaglobulinemia. J Clin Immunol. 2017;37(3):287–94.

    CAS  Google Scholar 

  21. Lee KH, Shyur SD, Chu SH, et al. Bruton syndrome and celiac disease. Asian Pac J Allergy Immunol. 2011;29:260–5.

    CAS  Google Scholar 

  22. Van den Bruele T, Mourad-Baars PE, Claas EC, et al. Campylobacter jejuni bacteremia and helicobacter pylori in a patient with X-linked agammaglobulinemia. Eur J Clin Microbiol Infect Dis. 2010;29:1315–9.

    Google Scholar 

  23. Brosens LA, Tytgat KM, Morsink FH, et al. Multiple colorectal neoplasms in X-linked agammaglobulinemia. Clin Gastroenterol Hepatol. 2008;6:115–9.

    Google Scholar 

  24. Halliday E, Winkelstein J, Webster AD. Enteroviral infections in primary immunodeficiency (PID): a survey of morbidity and mortality. J Infect. 2003;46:1–8.

    CAS  Google Scholar 

  25. Yazdani R, Fekrvand S, Shahkarami S, et al. The hyper IgM syndromes: epidemiology, pathogenesis, clinical manifestations, diagnosis and management. Clin Immunol. 2019;198:19–30.

    CAS  Google Scholar 

  26. National Center for Biotechnology Information. ClinVar; [VCV000643750.1], https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000643750.1

  27. Schwimmer D, Glover S. Primary immunodeficiency and the gut. Gastroenterol Clin N Am. 2019;48(2):199–220.

    Google Scholar 

  28. de la Morena MT, Leonard D, Torgerson TR, et al. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation. J Allergy Clin Immunol. 2017;139(4):1282–92.

    Google Scholar 

  29. Rahman M, Chapel H, Chapman RW, Collier JD. Cholangiocarcinoma complicating secondary sclerosing cholangitis from cryptosporidiosis in an adult patient with CD40 ligand deficiency: case report and review of the literature. Int Arch Allergy Immunol. 2012;159(2):204–8.

    Google Scholar 

  30. Bonilla FA, Barlan I, Chapel H, et al. International consensus document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4(1):38–59.

    Google Scholar 

  31. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency. Clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34–48.

    CAS  Google Scholar 

  32. Odetola O, Ananthanarayanan V. Gastrointestinal presentations of common variable immunodeficiency: hiding in plain sight. Arch Pathol Lab Med. 2019;143(4):525–30.

    CAS  Google Scholar 

  33. Song J, Lleo A, Yang GX, et al. Common variable immunodeficiency and liver involvement. Clin Rev Allergy Immunol. 2018;55(3):340–51.

    CAS  Google Scholar 

  34. Fiedorová K, Radvanský M, Bosák J, et al. Bacterial but not fungal gut microbiota alterations are associated with common variable immunodeficiency (CVID) phenotype. Front Immunol. 2019;10:1914–28.

    Google Scholar 

  35. Taki M, Miah T, Secord E. Newborn screening for severe combined immunodeficiency. Pediatr Clin N Am. 2019;66:913–23.

    Google Scholar 

  36. Cirillo E, Giardino G, Gallo V, et al. Severe combined immunodeficiency–an update. Ann N Y Acad Sci. 2015;1356:90–106.

    Google Scholar 

  37. Adeli MM, Buckley RH. Why newborn screening for severe combined immunodeficiency is essential: a case report. Pediatrics. 2010;126:465–9.

    Google Scholar 

  38. Ali YA, Rahman S, Bhat V, et al. Hereditary multiple intestinal atresia (HMIA) with severe combined immunodeficiency (SCID): a case report of two siblings and review of the literature on MIA, HMIA and HMIA with immunodeficiency over the last 50 years. BMJ Case Rep. 2011, 2011:3031–7.

    Google Scholar 

  39. Heimall J, Cowan MJ. Long term outcomes of severe combined immunodeficiency: therapy implications. Expert Rev Clin Immunol. 2017;13(11):1029–40.

    CAS  Google Scholar 

  40. Zama D, Biagi E, Masetti R, et al. Gut microbiota and hematopoietic stem cell transplantation: where do we stand? Bone Marrow Transplant. 2017;52(1):7–14.

    CAS  Google Scholar 

  41. Rider NL, Jameson MB, Creech CB. Chronic granulomatous disease: epidemiology, pathophysiology, and genetic basis of disease. J Pediatric Infect Dis Soc. 2018;7:2–5.

    Google Scholar 

  42. Falcone EL, Holland SM. Gastrointestinal complications in chronic granulomatous disease. Methods Mol Biol. 2019;1982:573–86.

    CAS  Google Scholar 

  43. Kang EM, Marciano BE, DeRavin S, et al. Chronic granulomatous disease: overview and hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2011;127:1319–26.

    Google Scholar 

  44. Keller MD, Notarangelo LD, Malech HL. Future of care for patients with chronic granulomatous disease: gene therapy and targeted molecular medicine. J Pediatric Infect Dis Soc. 2018;7:40–4.

    Google Scholar 

  45. Verbsky JW, Chatila TA. Immune dysregulation, polyendocrinophaty, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases. Curr Opin Pediatr. 2013;25:708–14.

    CAS  Google Scholar 

  46. Canani RB, Pezzella V, Grimaldi G, Russo M, et al. New insights and perspectives in congenital diarrheal disorders. Curr Pediatr Rep. 2017;5:156–66.

    Google Scholar 

  47. Bacchetta R, Barzaghi F, Roncarolo MG. From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation. Ann N Y Acad Sci. 2018;1417:5–22.

    CAS  Google Scholar 

  48. Charbit-Henrion F, Jeverica AK, Bègue B, et al. Deficiency in mucosa-associated lymphoid tissue lymphoma translocation 1: a novel cause of IPEX-like syndrome. J Pediatr Gastroenterol Nutr. 2017;64:378–84.

    Google Scholar 

  49. Alroqi FJ, Charbonnier LM, Keles S, et al. DOCK8 deficiency presenting as an IPEX-like disorder. J Clin Immunol. 2017;37:811–9.

    CAS  Google Scholar 

  50. Patey-Mariaud de Serre N, Canioni D, Ganousse S, et al. Digestive histopathological presentation of IPEX syndrome. Mod Pathol. 2009;22(1):95–102.

    CAS  Google Scholar 

  51. Barzaghi F, Amaya Hernandez LC, Neven B, et al. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study. J Allergy Clin Immunol. 2018;141:1036–1049.e5.

    Google Scholar 

  52. Zhu L, Shi T, Zhong C, Wang Y, Chang M, Liu X. IL-10 and IL-10 receptor mutations in very early onset inflammatory bowel disease. Gastroenterology Res. 2017;10:65–9.

    CAS  Google Scholar 

  53. Shim JO, Seo JK. Very early-onset inflammatory bowel disease (IBD) in infancy is a different disease entity from adult-onset IBD; one form of interleukin-10 receptor mutations. J Hum Genet. 2014;59:337–41.

    CAS  Google Scholar 

  54. Akkelle BS, Tutar E, Volkan B, et al. Gastrointestinal manifestations in children with primary Immunodeficiencies: single center: 12 years experience. Dig Dis. 2019;37:45–52.

    Google Scholar 

  55. Shah N, Kammermeier J, Elawad M, et al. Interleukin-10 and interleukin-10-receptor defects in inflammatory bowel disease. Curr Allergy Asthma Rep. 2012;12:373–9.

    CAS  Google Scholar 

  56. Engelhardt KR, Shah N, Faizura-Yeop I, et al. Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2013;131:825–30.

    CAS  Google Scholar 

  57. Huang Z, Peng K, Li X, et al. Mutations in Interleukin-10 receptor and clinical phenotypes in patients with very early onset inflammatory bowel disease: a Chinese VEO-IBD Collaboration Group Survey. Inflamm Bowel Dis. 2017;23:578–90.

    Google Scholar 

  58. Candotti F. Clinical manifestations and pathophysiological mechanisms of the Wiskott-Aldrich syndrome. J Clin Immunol. 2018;38:13–27.

    CAS  Google Scholar 

  59. Ochs HD, Filipovich AH, Veys P, Cowan MJ, Kapoor N. Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment. Biol Blood Marrow Transplant. 2009;15:84–90.

    Google Scholar 

  60. Ferrua F, Cicalese MP, Galimberti S, et al. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study. Lancet Haematol. 2019;6:239–53.

    Google Scholar 

  61. El-Chemaly S, Young LR. Hermansky-Pudlak syndrome. Clin Chest Med. 2016;37:505–11.

    Google Scholar 

  62. Girot P, Le Berre C, De Maissin A, Freyssinet M, Trang-Poisson C, Bourreille A. Crohn's-like acute severe colitis associated with Hermansky-Pudlak syndrome: a case report. World J Gastroenterol. 2019;25:1031–6.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Translational Medical Science, University of Naples Federico II, Naples, Italy

    Lavinia Di Meglio, Laura Carucci & Roberto Berni Canani

  2. Diagnostica Ecografica e Prenatale di A.Di Meglio, Naples, Italy

    Lavinia Di Meglio

  3. CEINGE Advanced Biotechnologies Research Center, University of Napes Federico II, Naples, Italy

    Laura Carucci & Roberto Berni Canani

  4. European Laboratory for the Investigation of Food Induced Diseases, University of Naples Federico II, Naples, Italy

    Roberto Berni Canani

Authors
  1. Lavinia Di Meglio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Carucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roberto Berni Canani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roberto Berni Canani .

Editor information

Editors and Affiliations

  1. Section of Pediatric Gastroenterology Hepatology and Nutrition, University of Chicago, Chicago, IL, USA

    Stefano Guandalini

  2. Pediatric Liver, GI and Nutrition Center, Child Health, King’s College Hospital, London, UK

    Anil Dhawan

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Di Meglio, L., Carucci, L., Berni Canani, R. (2022). Immunodeficiency Disorders Resulting in Malabsorption. In: Guandalini, S., Dhawan, A. (eds) Textbook of Pediatric Gastroenterology, Hepatology and Nutrition. Springer, Cham. https://doi.org/10.1007/978-3-030-80068-0_38

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-80068-0_38

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-80067-3

  • Online ISBN: 978-3-030-80068-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation